BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30917423)

  • 21. The value of detecting pepsinogen and gastrin-17 levels in serum for pre-cancerous lesion screening in gastric cancer.
    Yu G; Wang GX; Wang HG; Mo FF; Tang BB
    Neoplasma; 2019 Jul; 66(4):637-640. PubMed ID: 31058531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study.
    Kiso M; Yoshihara M; Ito M; Inoue K; Kato K; Nakajima S; Mabe K; Kobayashi M; Uemura N; Yada T; Oka M; Kawai T; Boda T; Kotachi T; Masuda K; Tanaka S; Chayama K
    Gastric Cancer; 2017 Sep; 20(5):764-771. PubMed ID: 28025702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
    Sun LP; Gong YH; Wang L; Gong W; Yuan Y
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2826-30. PubMed ID: 17200016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis.
    Watanabe M; Kato J; Inoue I; Yoshimura N; Yoshida T; Mukoubayashi C; Deguchi H; Enomoto S; Ueda K; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Tekeshita T; Mohara O; Ushijima T; Ichinose M
    Int J Cancer; 2012 Dec; 131(11):2632-42. PubMed ID: 22383377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the Value of Helicobacter pylori Test in Combination with the Determination of Plasma Propepsin and Gastrin 17 in Screening the Precancerous Status of Gastric Cancer.
    Xiao M; Zhang Z; Liao G; Liu M; Chen X
    Cell Mol Biol (Noisy-le-grand); 2022 Aug; 68(8):110-115. PubMed ID: 36800825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gastric cancer risk classification (ABC classification)].
    Inoue K
    Nihon Rinsho; 2013 Aug; 71(8):1472-8. PubMed ID: 23967682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between the GastroPanel test and the serum pepsinogen assay interpreted with the ABC method-A prospective study.
    Lee SY; Ahn YS; Moon HW
    Helicobacter; 2024; 29(1):e13056. PubMed ID: 38402559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection.
    Kwon Y; Jeon S; Nam S; Shin I
    Aliment Pharmacol Ther; 2017 Oct; 46(8):758-767. PubMed ID: 28799258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Actual Status of Involvement of Helicobacter pylori Infection That Developed Gastric Cancer from Group A of ABC (D) Stratification - Study of Early Gastric Cancer Cases That Underwent Endoscopic Submucosal Dissection.
    Miura K; Okada H; Kouno Y; Kanzaki H; Iwamuro M; Hori K; Kita M; Kawano S; Kawahara Y; Tanaka T; Yanai H
    Digestion; 2016; 94(1):17-23. PubMed ID: 27332718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Gastric cancer screening using ABC classification].
    Inoue K
    Nihon Rinsho; 2012 Oct; 70(10):1790-4. PubMed ID: 23198563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Characteristics of group A patients according to the ABC classification for gastric cancer risk screening].
    Yoshizawa K; Oizumi H; Sasaki Y; Abe Y; Kanno N; Sakuta K; Yagi M; Iwano D; Sato T; Nomura E; Nishise S; Ueno Y
    Nihon Shokakibyo Gakkai Zasshi; 2015 Aug; 112(8):1492-502. PubMed ID: 26250129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Serum Pepsinogen I and beta Helicobacter pylori Infection Are Risk Factors for Aspirin-Induced Gastroduodenal Injury.
    Shan J; Lei H; Shi W; Sun X; Tang Y; Ren C
    Dig Dis; 2018; 36(1):66-71. PubMed ID: 28595197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of leptin as marker for patients at high risk of gastric cancer.
    Capelle LG; de Vries AC; Haringsma J; Steyerberg EW; Looman CW; Nagtzaam NM; van Dekken H; ter Borg F; de Vries RA; Kuipers EJ
    Helicobacter; 2009 Dec; 14(6):596-604. PubMed ID: 19889078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of combined detection of three gastric functions and Helicobacter pylori typing in chronic gastritis and gastric cancer.
    Wang F
    SLAS Technol; 2024 May; ():100141. PubMed ID: 38710304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance evaluation of four prediction models for risk stratification in gastric cancer screening among a high-risk population in China.
    Hu Y; Bao H; Jin H; Zhao J; Xu Y; Huang X; Liu S; Lu B
    Gastric Cancer; 2021 Nov; 24(6):1194-1202. PubMed ID: 34152518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research.
    Tong Y; Wu Y; Song Z; Yu Y; Yu X
    BMC Gastroenterol; 2017 Jul; 17(1):88. PubMed ID: 28728545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1beta-511 polymorphisms are independent risk factors for gastric cancer in Thais.
    Yamada S; Matsuhisa T; Makonkawkeyoon L; Chaidatch S; Kato S; Matsukura N
    J Gastroenterol; 2006 Dec; 41(12):1169-77. PubMed ID: 17287896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study.
    Ikeda F; Shikata K; Hata J; Fukuhara M; Hirakawa Y; Ohara T; Mukai N; Nagata M; Yoshida D; Yonemoto K; Esaki M; Kitazono T; Kiyohara Y; Ninomiya T
    J Epidemiol; 2016 Dec; 26(12):629-636. PubMed ID: 27265836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg.
    Roman LD; Lukyanchuk R; Sablin OA; Araslanova EI; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
    Anticancer Res; 2016 Aug; 36(8):4129-38. PubMed ID: 27466521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori Antibody Titer and Gastric Cancer Screening.
    Kishikawa H; Kimura K; Takarabe S; Kaida S; Nishida J
    Dis Markers; 2015; 2015():156719. PubMed ID: 26494936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.